Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

take note of the cold reception Pfizer CEO Albert Bourla got at the White House, and more. From STAT’s Jason Mast: Bluebird Bio announced this morning it would sell itself and its portfolio of ...

FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...

Pfizer reacts to Donald Trump’s tariff threats on big pharma, another regulatory meeting is canceled under RFK Jr., AbbVie ...

The healthcare giant, in July 2023, acquired Versanis Bio for ... Last year, Pfizer (NYSE:PFE) decided to proceed with the development of a once-daily formulation of its oral weight-loss drug, ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total ...

"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...

An icon in the shape of a lightning bolt. Impact Link Albert Bourla, Pfizer's CEO, said on Monday that the company may move overseas drug manufacturing back to the US if President Donald Trump's ...

Pfizer CEO Dr. Albert Bourla and chair of the PhRMA Board of Directors Pharmaceutical Research and Manufacturers of America (PhRMA) Pfizer CEO Dr. Albert Bourla and chair of the PhRMA Board of ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert Bourla, Ph.D., outlined one potential response by his company if ...